Clinical Edge Journal Scan

Weight control has direct and indirect impact in reducing breast cancer risk


 

Key clinical point: Association of body mass index (BMI) with cardiometabolic risk score (CRS) and obesity-related protein score (OPS) and the relation between CRS and OPS in postmenopausal women indicated that weight control for the reduction of cardiometabolic risks may also help prevent breast cancer (BC).

Major finding: A 1-kg/m2 increase in BMI per year increased CRS in both premenopausal (0.057 units; P = .025) and postmenopausal women (0.054 units; P = .033) and increased OPS by 0.588 units (P = .001) in postmenopausal women. A significant association was also observed between CRS and OPS in post-menopausal women (β 0.281, P = .034).

Study details: This longitudinal study included 444 healthy women age 35-64 years.

Disclosures: This study was funded by the National Natural Science Foundation of China and other sources. The authors declared no conflicts of interest.

Source: Xu B et al. Temporal relationships between BMI and obesity-related predictors of cardiometabolic and breast cancer risk in a longitudinal cohort. Sci Rep. 2023;13:12361 (Jul 31). doi: 10.1038/s41598-023-39387-w

Recommended Reading

Alcohol consumption may not influence breast cancer prognosis, study
MDedge Hematology and Oncology
Higher chances of BC overdiagnosis among older women
MDedge Hematology and Oncology
Breast cancer diagnosis and treatment may accelerate biological aging
MDedge Hematology and Oncology
Metronomic oral vinorelbine, cyclophosphamide, and capecitabine may be a chemotherapy option in ER+/ERBB2− advanced BC
MDedge Hematology and Oncology
Axillary lymph node dissection omission does not affect systemic therapy recommendations in cN+ BC
MDedge Hematology and Oncology
Elevated plasma apolipoprotein M level associated with reduced mortality in ER+/HER2− metastatic BC
MDedge Hematology and Oncology
T1-2N0 ER− BC: Most, if not all, elderly women benefit from adjuvant radiotherapy
MDedge Hematology and Oncology
ER+/HER2+ BC: Fulvestrant shows promise both with and without anti-HER2 therapy
MDedge Hematology and Oncology
Metformin may protect against paclitaxel-induced peripheral neuropathy in BC
MDedge Hematology and Oncology
Meta-analysis shows association between diabetes and different BC subtypes in postmenopausal women
MDedge Hematology and Oncology